Liver Cancer Diagnostics Market contains market size and forecasts of Liver Cancer Diagnostics in Global, including the following market information:
- Global Liver Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Liver Cancer Diagnostics market was valued at 33 million in 2021 and is projected to reach US$ 45 million by 2028, at a CAGR of 4.4% during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Biopsy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Liver Cancer Diagnostics include Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Liver Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liver Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Biopsy
- Endoscopy
- Laboratory Tests
- Imaging
- Others
Global Liver Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liver Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Laboratory
Global Liver Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liver Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Liver Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Liver Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- BD
- Roche Holding AG
- Fujifilm Healthcare
- Hologic
- Illumina
- Philips
- Oncimmune
- Qiagen
- Siemens Healthineers
- Sirtex Medical
Industry Market Size
